Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles Davis

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Vaccines|June 27, 2024
Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated CancerMohsen Mohammadi, Amara Saha, Wynetta Giles-Davis, et al.
Journal of Immunological Methods|June 1, 2001
A method that allows easy characterization of tumor-infiltrating lymphocytesD W Kowalczyk, A P Wlazlo, M Blaszczyk-Thurin, et al.
Cancer Gene Therapy|January 9, 2004
Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attackDariusz W Kowalczyk, Anthony P Wlazlo, Wynetta Giles-Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriersArguinaldo R Pinto, Julie C Fitzgerald, Wynetta Giles-Davis, et al.
Virology|April 25, 2000
Viral recombinant vaccines to the E6 and E7 antigens of HPV-16Z He, A P Wlazlo, D W Kowalczyk, et al.
Cellular Immunology|July 27, 2002
A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell lineHonying Deng, Dariusz Kowalczyk, InSug O, et al.
Journal of Immunological Methods|January 29, 2000
In situ stimulation of a T helper cell hybridoma with a cellulose-bound peptide antigenL Otvos, A M Pease, K Bokonyi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in miceHua Li, Steven Tuyishime, Te-Lang Wu, et al.
Molecular Therapy Oncolytics|December 11, 2023
Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8<sup>+</sup> T cell therapy for melanomaMohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, et al.
European Journal of Immunology|November 26, 2010
Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gagLarissa H Haut, Shih W Lin, Nia Tatsis, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Vaccines|June 27, 2024
Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated CancerMohsen Mohammadi, Amara Saha, Wynetta Giles-Davis, et al.
Journal of Immunological Methods|June 1, 2001
A method that allows easy characterization of tumor-infiltrating lymphocytesD W Kowalczyk, A P Wlazlo, M Blaszczyk-Thurin, et al.
Cancer Gene Therapy|January 9, 2004
Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attackDariusz W Kowalczyk, Anthony P Wlazlo, Wynetta Giles-Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriersArguinaldo R Pinto, Julie C Fitzgerald, Wynetta Giles-Davis, et al.
Virology|April 25, 2000
Viral recombinant vaccines to the E6 and E7 antigens of HPV-16Z He, A P Wlazlo, D W Kowalczyk, et al.
Cellular Immunology|July 27, 2002
A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell lineHonying Deng, Dariusz Kowalczyk, InSug O, et al.
Journal of Immunological Methods|January 29, 2000
In situ stimulation of a T helper cell hybridoma with a cellulose-bound peptide antigenL Otvos, A M Pease, K Bokonyi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in miceHua Li, Steven Tuyishime, Te-Lang Wu, et al.
Molecular Therapy Oncolytics|December 11, 2023
Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8<sup>+</sup> T cell therapy for melanomaMohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, et al.
European Journal of Immunology|November 26, 2010
Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gagLarissa H Haut, Shih W Lin, Nia Tatsis, et al.
Pageof 4